CuriousTabby

[Scott Brooks @scotti_brooks]

Legs up the wall. 5 minutes.

The simplest pose in yoga. The most underrated medicine your body has access to.

Here how to do it and why.. 🧵 👇

[CuriousTabby @CuriousTabby]

@felixprehn workbook

[CuriousTabby @CuriousTabby]

@NoLimitGains According to Gemini:
In Mainland China, red indicates market price gains and green indicates market price losses. This rule applies consistently to both candlesticks and market heatmaps on domestic financial platforms.

[Afshine Emrani MD FACC @afshineemrani]

I'm a cardiologist. After 40, stop guessing about your health. These numbers tell you whether you're building a long, vibrant life — or quietly declining without knowing it.

I run these on myself. I run them on every patient I care about. Most are cheap bloodwork. All are available now. And together, they paint a picture no standard annual physical will ever give you. Print this. Bring it to your next appointment. Your 60-year-old self will thank you.
ꟷꟷꟷ
𝗙𝗮𝘀𝘁𝗶𝗻𝗴 𝗜𝗻𝘀𝘂𝗹𝗶𝗻
Target: below 5 μIU/mL. Ideal: 3-4.
This is the 10-year warning bell your standard panel completely misses. Your glucose and A1c can look "normal" for a decade while your pancreas is working overtime to keep them there. Fasting insulin catches insulin resistance 5-10 years before your A1c moves. By the time A1c rises, the damage is already extensive.

𝗛𝗢𝗠𝗔-𝗜𝗥
Target: below 1.0.
Calculated from fasting insulin and fasting glucose. The single best measure of insulin sensitivity. Above 1.0 and your metabolism is already under strain. Above 2.5 and you're insulin resistant — even if every other number looks fine.

𝗛𝗯𝗔𝟭𝗰
Target: below 5.4%.
Not below 5.7% — that's the threshold where medicine calls you "prediabetic." By then you've been metabolically compromised for years. Optimal is below 5.4%. Blood sugar mastery is longevity mastery.

𝗧𝗿𝗶𝗴𝗹𝘆𝗰𝗲𝗿𝗶𝗱𝗲 : 𝗛𝗗𝗟 𝗥𝗮𝘁𝗶𝗼
Target: below 2. Ideal: below 1.
Your metabolic health crystal ball. This ratio predicts insulin resistance, cardiovascular risk, and metabolic syndrome better than any single lipid number alone. A ratio above 3.5 is a red flag regardless of what your total cholesterol says.

𝗔𝗽𝗼𝗕
Target: below 80 mg/dL for moderate risk. Below 60 for high risk.
I've written about this extensively. ApoB counts every atherogenic particle hitting your artery walls. A 2024 analysis found 54% of patients had dangerous levels that standard LDL testing completely missed. If you only know your LDL, you're driving with one eye closed.

𝗟𝗽(𝗮)
Test once in your lifetime.
100% genetic. 1 in 5 Americans are elevated. Triples heart attack risk independently of everything else on this list. Diet and exercise cannot lower it. The 2026 ACC/AHA guidelines now recommend everyone be tested. Most never have been.

𝗵𝘀-𝗖𝗥𝗣
Target: below 1.0 mg/L.
You can have perfect cholesterol and inflamed arteries silently preparing to rupture. hs-CRP measures the fire behind the plaque. The JUPITER trial proved that finding and treating inflammation saves lives — even when lipids look fine. If this number is elevated, your mouth, your gut, your metabolic health, and your visceral fat are the first places to investigate.

𝗩𝗶𝘁𝗮𝗺𝗶𝗻 𝗗
Target: 50-80 ng/mL.
Not the bare minimum of 30 your doctor accepts. Suboptimal vitamin D is linked to higher inflammation, weaker immunity, increased cardiovascular events, worse mood, and poorer outcomes across nearly every disease I treat. Supplement D3 with K2 — without K2, calcium deposits in your arteries instead of your bones.

𝗧𝗲𝘀𝘁𝗼𝘀𝘁𝗲𝗿𝗼𝗻𝗲 (𝗧𝗼𝘁𝗮𝗹 + 𝗙𝗿𝗲𝗲)
Men: optimal range 600-1000+ ng/dL total.
Declining testosterone is an independent predictor of cardiovascular death in men. It's tied to insulin resistance, arterial stiffness, visceral fat accumulation, and systemic inflammation. DHEA-S drops 10-20% every decade after 30. Tracking these isn't about vanity — it's evaluating your body's systemic resilience.

𝗕𝗹𝗼𝗼𝗱 𝗣𝗿𝗲𝘀𝘀𝘂𝗿𝗲
Target: below 120/80. Aim closer to 110/70.
Every point above optimal is cumulative arterial damage. Buy a home cuff. Measure morning and evening, seated quietly for five minutes, arm at heart level. White-coat readings in the office miss what's really happening. The smartest $40 investment in cardiac self-care.

𝗩𝗢𝟮 𝗠𝗮𝘅
Men over 40: above 40 mL/kg/min. Women over 40: above 35.
Cardiorespiratory fitness is the single strongest predictor of all-cause mortality — stronger than smoking, diabetes, or heart disease as individual risk factors. A landmark study in JAMA found that extreme fitness was associated with the lowest mortality with no upper limit of benefit. You can estimate VO2 max with a timed mile, a rower test, or a wearable. Get faster every year.

𝗡𝘂𝗺𝗯𝗲𝗿 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀
Target: as few as possible.
Every medication you're on should be earning its place. I just wrote about five commonly prescribed drugs that do more harm than good with long-term use. Bring your full medication list to every appointment. Ask: "Do I still need this?" Deprescribing is one of the most powerful and underused tools in medicine.
ꟷꟷꟷ

Thirteen numbers. Most available through cheap bloodwork and simple tests. Get them once or twice a year. Here's what I want you to understand: these numbers don't just tell you where you are. They tell you where you're heading. A fasting insulin of 8 today becomes diabetes in five years. An ApoB of 120 today becomes a heart attack in ten. An hs-CRP of 3 today means your arteries are inflamed right now — regardless of how healthy you feel. The standard annual physical checks a fraction of these. It was designed to find disease that's already there. This panel finds the disease that's coming — years before it arrives.

What gets measured gets improved. Optimize with the foundation I write about every week on this platform:
Zone 2 cardio plus resistance training 3-4 times per week. High-protein whole-food nutrition. Sleep 7-9 hours — non-negotiable. Morning sunlight. Stress management. And the targeted supplements I've covered in detail — creatine, magnesium, CoQ10, D3+K2, glycine, omega-3, psyllium husk.
The breakthroughs coming in the next decade — gene editing for cholesterol, cellular reprogramming, senolytics that clear senescent "zombie" cells driving inflammation and aging, GLP-1 drugs rewriting metabolic medicine — will be most powerful for people who've already built the metabolic foundation to receive them.

The future of medicine is personalized. But it starts with knowing your numbers today. Print this list. Book the bloodwork. Own the data. Prevention isn't passive. It's the most aggressive thing you can do for the decades ahead.

[Mark @Mark4XX]

YEN DOOM LOOP IGNITES: HOW TOKYO'S OIL SHOCK WILL UNWIND YOUR PORTFOLIO IN WEEKS

Jay Martin, host of The Jay Martin Show and the Vancouver Resource Investment Conference, just delivered a clear warning. Japan is the canary in the global economic mineshaft. The bird has stopped singing, and the gas is already moving.

THE CANARY IN THE MINESHAFT
➡️ For 75 years British coal miners carried a small cage with one bird inside. When the canary stopped singing, they ran for their lives.
➡️ Japan now plays that exact role for the world economy.
➡️ The country produces roughly 100,000 barrels of oil per day but burns about 3 million.
➡️ It imports 97 percent of its energy, almost all of it through the Strait of Hormuz.
➡️ The yen has fallen to levels not seen in nearly 40 years and keeps dropping.

THE DEBT EXPERIMENT THAT STARTED IN TOKYO
➡️ At the end of 1989 Japan was the envy of the planet. Its stock market peaked above 38,000 and land under the Imperial Palace was said to be worth more than the entire state of California.
➡️ Then the bubble burst and never truly recovered.
➡️ Japan cut interest rates to zero in 1999, nearly a decade before the Federal Reserve.
➡️ It launched the world's first quantitative easing program in 2001, seven years before the term entered American vocabulary.
➡️ In 2016 it pioneered yield curve control, pinning government borrowing costs wherever it wanted by printing whatever money it took.
➡️ Everything the Federal Reserve reached for after 2008, Japan reached for first.

THE SAVINGS MOUNTAIN THAT BOUGHT DECADES
➡️ Japanese citizens and companies became some of the most disciplined savers on Earth.
➡️ For 34 years they were the world's largest creditor nation, lending trillions abroad while still funding most of their own government's debt at home.
➡️ That single mountain of savings did two jobs at once until now.

THE OIL SHOCK DOOM LOOP
➡️ A falling yen and a blocked Strait of Hormuz create a self-reinforcing spiral.
➡️ Every time the yen drops, Japan's oil bill rises in local currency.
➡️ That forces more yen selling to buy the next cargo of oil, which weakens the currency further and makes the following bill even larger.
➡️ The Bank of Japan can no longer print unlimited yen to buy government bonds without accelerating the exact spiral it fears most.
➡️ Borrowing costs are now rising at the same moment the currency collapses.

THE YEN CARRY TRADE THAT CONNECTS TOKYO TO YOUR ACCOUNT
➡️ For decades investors borrowed cheap yen at nearly zero cost, converted them into dollars, and bought higher-yielding assets worldwide.
➡️ That free money quietly supported markets from stocks to real estate to corporate bonds.
➡️ The day Japanese rates rise or the yen strengthens, the math flips and everyone rushes to unwind at the same time.
➡️ August 2024 gave the preview. A single quarter-point rate hike from the Bank of Japan sent Tokyo down 12.4 percent in one day and gave Wall Street its worst session in two years.

AMERICA IS ALREADY HALFWAY DOWN THE SAME ROAD
➡️ The United States now carries more than 39 trillion dollars in debt with annual interest costs topping one trillion.
➡️ It sits at roughly 125 percent debt to GDP and continues climbing.
➡️ Japan shows what 30 years of the same central bank tools actually deliver: a currency sliding to generational lows, savers earning almost nothing for decades, and an economy that barely grows.
➡️ America still holds the reserve currency advantage, but the destination after the next decade looks dangerously familiar.

THE BOTTOM LINE

Japan believed it was exceptional in 1989. It was not. The same belief exists in other capitals today. The canary has stopped singing. Head for the exit before the gas arrives.

The bird stopped singing. Position for hard assets and real things before the slow death of paper promises reaches everyone else.

#JapanCanary #YenCarryTrade #DebtTrap #OilShock #HardAssets #EconomicWarning #MarketReality

[CuriousTabby @CuriousTabby]

@BillBrooklyn10 Thank you!

[CuriousTabby @CuriousTabby]

@StephenSBrown28 @gregoryblotnick In his speech Bessent only mentioned Alex Soros, the son of George Soros (whom he worked for).

[bodila @51bodila]

Scott Bessent traded with Soros and Druckenmiller against governments for 20 years - now he's Trump's United States Treasury Secretary

he generated $10 billion in total profits for Soros:

- $1B collapsing the British economy in one day

- then told Soros about Japan: "a once-in-a-lifetime market move is coming " - and made another $1.2B

Stan Druckenmiller personally mentored him

George Soros invested $2B in his fund when he left

Bessent launched one of the largest hedge fund in history - $4.5B in 6 months

Scott literally broke the banks of Britain and Japan - now he manages the finances of the United States

bookmark & watch today

[Lance Roberts @LanceRoberts]

The "pattern matching" tool from @NDR_Research shows the Nasdaq tracking the https://t.co/PCNfBkK0Kp bubble but is closer to 1998 than 2000. This aligns with our view that a corrective process is coming but you should likely be a buyer than a seller for now. (Assuming the analog remains, but that is always the question.)

[CuriousTabby @CuriousTabby]

@t_mktstructure @BoxTraderVK Just checked on your website but didn't see an obvious screening tool for Qullamagie swing candidates. Could you outline the steps one should take for that purpose? Thanks.

[dylan ツ @demian_ai]

What is the smallest object that, if it stopped being made tomorrow, would freeze the entire AI industry by Friday?

Not a chip. Not a GPU. Not a model.

A polished piece of indium phosphide the size of a coaster, grown in a furnace over two weeks, made by exactly two companies in the world that are not Chinese.

I learned that around 4 a.m. one night about two years ago. I have not really stopped thinking about it since.

To understand why a coaster of crystal can hold up a trillion-dollar industry, you first have to understand that almost nothing about modern computing is normal.

A leading-edge AI chip travels through roughly a thousand process steps over three to four months. The cleanroom it lives in is thousands of times cleaner than a hospital operating room. The fab itself draws as much electricity as a small city. The single lithography machine that draws the circuits has five thousand suppliers of its own, spread across six countries, and not a single nation on Earth could build one alone. By the time a finished chip pops out the other end, more humans have had a hand in its production than live in most American towns. Most of them will never meet.

From the highway, a TSMC fab looks like a beige warehouse with a parking lot. Inside, it is the closest thing humans have ever built to alien technology.

I find that genuinely moving. And I find it terrifying. Because a miracle that complicated has a lot of single points of failure, and almost nobody in mainstream coverage is mapping them.

Two years of pulling on this thread keeps bringing me back to the same conclusion. The 2026 to 2030 AI buildout is gated by four physical constraints, and almost nothing else.

1. Indium phosphide wafers. Two credible non-Chinese suppliers in the world.
2. Advanced packaging. Four companies on Earth that matter.
3. Power. Industrial gas turbines sold out into 2030. Three vendors at scale.
4. Critical minerals. China's pause on gallium, germanium, and antimony export controls expires November 27, 2026.

By the time a chokepoint is on the front page, the move is largely over. The prize goes to whoever was patient enough to map the chain when it was boring.

So I built a dashboard

A free public dashboard. The chokepoints, the names that own them, the live prices, the catalysts, and the written thesis all on one screen. No login. No newsletter. Not a portfolio. Not a recommendation. A prism.

I wanted it free because the people I would have wanted to read this when I was younger could not have afforded a Bloomberg terminal. Students. Engineers. Journalists trying to understand what they are writing about. Retail investors tired of being sold someone else's conviction. Curious teenagers in countries where the local financial press is twenty years behind the actual frontier.

The chain deserves to be walked. That is the whole invitation.

links below 👇

Educational, not investment advice.

[Serenity @aleabitoreddit]

Just a recap of recent information discovery + likely mapping with $SIVE:

-> $JBL 1.6T
-> Lightmatter
-> Ayar
-> $MRVL Celestial
-> Lightelligence
-> $POET
-> $GFS ecosystem
-> $AMD CPO
-> O-Net / Enablence
-> $AAPL Silicon Photonics
_
-> $YSS Golden Dome/DoD
-> $RTX / $ERIC (Space)
-> Bae Systems
-> $AEVA

With $JBL to Ayar feeding into hyperscalers like $MSFT, $GOOGL, $AMZN, $META.

With likely Lightelligence to O-Net feeding into Asian Hyperscalers like Tencent, Bytedance, and Baidu.

On top of that... the overarching TAM with CPO from the GS report goes from 0 -> $91B.

And Sivers happens to be the bleeding edge for CPO (also starting from 0).

This is definitely high-beta and volatile.

But if Win volume ramps alongside $SIVE, I see them both becoming $10B+ companies next year.

This is just extremely early on (H1) before the CPO supercycle starts H2 2026.

[Venu @Venu_7_]

I ran William O’Neil’s CANSLIM screen across the entire US market.

Out of thousands of stocks, these are the top 50.

The #1 name is up +400% YTD, just hit an all-time high, and EPS is growing 400%+ YoY - $SNDK

Here are all 50 names, grouped by sector (many you’ve likely never heard of).

Follow this thread 🧵

[حسن إسميك @HasanIsmaik]

Dear Readers, Donald Trump is not like any other U.S. president. He may appear to some as temperamental, sharp in tone, and quick to anger, but at his core he is a highly intelligent and stubborn figure who knows exactly what he wants and how to achieve it. Behind the apparent chaos he creates lies a precise, calculating mind—one that weighs its steps with a balance of fire and cunning. Moreover, he can read his opponents as if they were open pages in a book.

He is neither as the media portrays him nor as his opponents wish him to be. Aside from his bombastic rhetoric, he neither deceives nor is easily deceived. He detects attempts at maneuvering before they begin and rejects without accomodation any delay. This is why Iran has not been fortunate in his return to the White House, as it now faces a man who looks at it with an eye that distinguishes between rhetoric and substance, intentions and tactics.

Yet Trump is not bloodthirsty. He opposes wars in principle and believes that limited sacrifice may be the price of saving an entire nation. He understands that if the ruling elite in Iran do not change their approach, their continued rule means the continued suffering of the people. He is also aware that nearly 90 million Iranians live between poverty and the lower middle class, aspiring to rebuild their country much as Germany did after World War II when it transformed itself into a strong and respected nation in which citizens enjoy stability and confidence in the future.

From this perspective, Trump focuses on reviving the interests of people rather than regimes, viewing the change of ruling elites—despite its cost—as a gateway to comprehensive progress that benefits millions of Iranians.

Iran is but one example among many. Trump does not forget, nor does he leave matters unresolved. He returns to complex files with a sharp focus that allows for calculated opportunities that other leaders missed or dismissed. The Syrian file, for instance, is not far from his attention. Those who believe they have bypassed or deceived Trump on this issue will soon discover they are facing a man who neither forgets nor retreats until he imposes his terms in full.

It is also evident that he is steadily moving toward confronting authoritarian regimes, as his logic is rooted in breaking the closed cycles of oppression people suffer from within such systems. Venezuela was first, Iran is now, and perhaps Cuba will follow.

At the same time, Trump is loyal and sincere to those who respect him or deal with him in good faith. Behind his harsh language is a practical individual who values work and achievement and seeks to accomplish something meaningful for his country that changes reality for the better. His blunt candor may be seen by some as a flaw, but he considers it a strength, as clarity for him is a virtue, not a shortcoming.

For this reason, those who see him as merely an outlier among U.S. presidents do not truly understand him. He has established an approach that will endure as long as America seeks to renew its strength: Make America Great Again. This is not just a slogan, but a doctrine Donald J. Trump initiated—one that will persist and only grow stronger and more influential over time.

[CuriousTabby @CuriousTabby]

@AndrewKolvet ..."the legacy media practically cheering this on is disgusting". Indeed.

[Paper Gains @PaperGainsInc]

Richard Wyckoff published this blueprint in 1910
Over 100 years ago

$MU is following it step-by-step RIGHT NOW

UTAD - fake breakout to trap longs
SOW - sign of weakness
LPSY - last chance to sell

The blueprint said what comes next

[Washingtons ghost @washghost1]

I hope I keep my sense of humor this long

[Whiplash347 @Whiplash437]

IVERMECTIN AND FENBENDAZOL END CANCER
🎯CONFIRMED: Epidemiologist Nicolas Hulscher states that complete remissions of stage IV cancers using antiparasitic drugs are already documented in peer-reviewed scientific literature.

According to him, hundreds of studies show that ivermectin and fenbendazole activate more than 12 different anticancer mechanisms and act against more than a dozen types of cancer.

Among the most impactful works cited by Hulscher is a case report published in Case Reports in Oncology.

There, three patients with metastatic stage IV cancer are described who achieved complete remission documented by imaging and tumor markers:

📌An 83-year-old woman with breast cancer that had metastasized to the liver, lungs, and bones. After treatment, the PET scan showed complete remission, and she has shown no recurrence in nearly three years.

📌A 75-year-old man with metastatic bone prostate cancer. His PSA dropped to undetectable levels, and the metastases disappeared completely.

📌A 63-year-old man with highly advanced BRAFV600+ melanoma. His circulating tumor DNA went from 123 to 0 in less than two months, with confirmed remission.

Additionally, a recent systematic review analyzed 26 studies with 36 real patients treated with ivermectin. No serious adverse effects were reported, and clinical improvements were observed even in cases of leukemias and lymphomas, many of them while continuing to receive conventional chemotherapy.

Alternative scientists explain that these drugs attack cancer in multiple ways: they destabilize microtubules, induce programmed apoptosis, block the mTOR pathway, cut off the glucose supply to tumor cells, inhibit the formation of new blood vessels, and eliminate cancer stem cells.

All this with medications that cost pennies and have been used in humans and animals for decades.

While conventional medicine invests billions in high-cost therapies, on social media thousands of patients are already sharing personal testimonials: tumors that shrink or disappear, markers that normalize, and surgeries that end up being canceled.

The question sweeping the world is whether this represents the greatest medical suppression in history or the most important discovery of the 21st century. The dissenting scientific community demands controlled clinical trials with urgency. For many terminal cancer patients, time has simply run out.

What do you think? Give it an RT and share this information before it disappears, as it could save many lives. Your friends or family fighting cancer need to read this today.

[Kacper Piotr Kaminski @Kacper_PK_CH]

MIDDLE EAST OIL & GAS RECONSTRUCTION WATCHLIST

Who rebuilds when this war ends? Ranked by reconstruction relevance, not pre-war backlog, assembled by AI assistant, hopefully 95% accurate.

PHASE 1: Emergency restart and damage repair (months 1 to 12 post ceasefire)

1. $SLB (NYSE) | SLB N.V. | Largest installed base of wellhead systems and production equipment across every damaged facility. Well restart, integrity assessment, corrosion monitoring after prolonged shut ins. Recently won $1.5B Kuwait Oil Company contract plus Oman contracts. Biggest regional footprint of any OFS company.

2. $HAL (NYSE) | Halliburton | Well intervention, cementing, completions restart. Holds the $2.5B Jafurah EPIC contract with Aramco. Dual HQ in Houston and Dubai. Critical for restarting shut in wells across Saudi and UAE.

3. $BKR (NASDAQ) | Baker Hughes | Gas turbine inspection, compressor recertification, gas processing equipment stress testing. Every gas plant shut down (Habshan, Shah, Ras Laffan) needs their turbomachinery services before restart.

PHASE 2: Full reconstruction (years 1 to 5)

4. $TE (Euronext Paris) / $THNPY (OTC) | Technip Energies | Built most of Qatar's LNG infrastructure. 59% of revenue from Africa and Middle East. The Ras Laffan rebuild alone could be their largest contract in history.

5. $KBR (NYSE) | KBR Inc. | Brownfield EPCM specialists. Already supporting Aramco's Shaybah (attacked), Majnoon in Iraq, and Kuwait Oil Company. Damage assessment to design to reconstruction.

6. $FLR (NYSE) | Fluor Corporation | Major refinery rebuild expertise. Ras Tanura, SAMREF are historical Fluor client base. Also positioned for new bypass infrastructure EPC.

7. $SPM (Borsa Italiana) / $SAPMY (OTC) | Saipem | Deep Gulf NOC relationships. Merging with Subsea 7 to form Saipem7 with EUR 43B combined backlog. Offshore and pipeline repair in the Gulf runs through them.

PHASE 3: New infrastructure that didn't exist before

8. $TS (NYSE) | Tenaris | World's largest steel pipe manufacturer for oil and gas. Post war bypass pipeline expansion means potentially hundreds of km of new pipeline. Massive pipe orders.

9. $WFRD (NASDAQ) | Weatherford International | Production restart, artificial lift, well services. Major contracts with PDO, KOC, Bapco. Positioned for the activity surge when operations resume.

10. $FTI (NYSE) | TechnipFMC | Subsea and surface wellhead systems. Essential for offshore Gulf infrastructure repair and new subsea pipeline connections.

11. $HP (NYSE) | Helmerich and Payne | Was scaling to 24 rigs in Saudi Arabia by mid 2026. Rigs are likely idle now. When drilling resumes expect a massive catch up surge. Rigs already in country.

12. $PTEN (NASDAQ) | Patterson UTI Energy | 15% stake in JV with ADNOC Drilling and SLB to drill 144 unconventional wells in UAE. That program restarts post war with urgency.

13. $NOV (NYSE) | NOV Inc. | Rig systems, drilling equipment, pipeline components. Equipment supplier to every company above. Picks and shovels play on the entire rebuild.

Map by https://t.co/2cHBEBHnIQ